| GTO ID | GTC3862 |
| Trial ID | NCT06381830 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | Apheresis |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study of the Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Following Autologous Stem Cell Transplantation for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma |
| Year | 2024 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Soochow University |
| Other ID(s) | ASCT+CART |
| Cohort 1 | |||||||||||
|
|||||||||||